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Introduction
============

The two major forms of motoneuron disease, proximal spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis, are caused by selective cell death of motoneurons. Among the mechanisms that are thought to play a central role are cell- autonomous mechanisms like oxidative stress and mitochondrial dysfunction ([@bib30]), but also nonautonomous processes such as dysregulated signaling from neighboring glial cells and contacting neurons ([@bib1]; [@bib44]). Such mechanisms have been studied in great detail for amyotrophic lateral sclerosis ([@bib2]). In contrast, much less is known for proximal SMA, the most common form of motoneuron disease in children and young adults ([@bib6]; [@bib41]; [@bib42]; [@bib13]). This disease is caused by homozygous loss or mutations in the telomeric copy (*SMN1*) of the survival of motor neuron gene (*SMN*; [@bib19]) on human chromosome 5q13. Whereas the *SMN1* gene allows expression of a functionally intact full- length protein, most of the transcripts from the *SMN2* gene code for a truncated protein lacking the functionally important domains at the C terminus that are encoded by exon 7 ([@bib21]; [@bib25]). Nevertheless, low expression of full-length Smn protein from the *SMN2* gene occurs, but this is not sufficient for compensating the defect caused by *SMN1* loss, thus leading to motoneuron disease in humans. In contrast to humans, mice carry only one *Smn* gene, and the homozygous knockout of the *Smn* gene in mice is lethal in early development, even before blastocysts are formed ([@bib36]).

The *Smn* gene is ubiquitously expressed, thus raising the question of how reduced levels of this protein lead to specific motoneuron disease. Smn plays a role in the assembly and in recycling of spliceosomal uridine-rich small nuclear RNPs ([@bib23]; [@bib31]). Dysfunction of such processes should lead to severe defects in all cell types. The clinical phenotype of patients with SMA indicates that low levels of SMN protein, both in the full-length and the truncated form lacking the exon 7--encoded domains, are sufficient for development, survival, and function of most types of cells, but not for motoneurons. It has therefore been hypothesized that motoneurons are more vulnerable, possibly because they are among the biggest cells in the body and their need for proper mRNA expression, processing, and translation is probably higher than in other cell types ([@bib24]). This hypothesis is supported by the observation that injection of assembled small nuclear RNP complexes into early Smn-deficient zebrafish embryos can rescue defects in motoneurons ([@bib47]).

A mouse model for SMA has been generated by introducing the human *SMN2* into a mouse *Smn* null background ([@bib26]). The phenotype of these mice closely resembles that of humans. These mice develop severe paralysis within a few days after birth and normally die between postnatal day 1 and 5. Surprisingly, the loss of motoneuron cell bodies at late stages of the disease does not exceed 20%, suggesting that most motoneurons develop normally during embryogenesis and that disease becomes apparent before the majority of motoneurons are lost. Survival of spinal motoneurons that are isolated from *Smn* ^−*/*−^ *; SMN2* embryos does not differ from control motoneurons (*Smn* ^+/+^; *SMN2*). However, they exhibit a specific defect in axon elongation that correlates with a defect in β-actin mRNA translocation to distal axons ([@bib35]).

To study the underlying pathomechanism in Smn-deficient motoneurons, we have analyzed the functional consequences of Smn deficiency in growth cones. Smn-deficient motoneurons show defects in spontaneous excitability, and these defects correlate with reduced integration of voltage-gated Ca^2+^ channels (VGCCs) into axonal growth cones. Treatment with cAMP increases Smn levels in *Smn* ^−*/*−^ *; SMN2* motoneurons and leads to restoration of the morphological and functional deficits in axons and axon terminals. These findings indicate that reduced excitability in growth cones contributes to the disease phenotype. This defect could lead to disturbances of active zones in the presynapse, causing reduced transmitter release at the motor endplate that, in turn, could contribute to motoneuron malfunction and degeneration in SMA.

Results
=======

Spontaneous excitability is reduced in cultured Smn-deficient motoneurons
-------------------------------------------------------------------------

In isolated embryonic *Smn* ^−*/*−^ *; SMN2* motoneurons, translocation of β-actin mRNA to distal axons and growth cones is disturbed ([@bib35]). To investigate the functional consequences of Smn deficiency in axon terminals, we measured spontaneous excitability in motoneurons that were isolated from embryonic day (E) 14 of control and *Smn* ^−*/*−^ *; SMN2* mutant mouse embryos, and cultured them on laminin-111. The cultured neurons were loaded with Fura-2, a Ca^2+^-binding fluorescent dye ([Fig. 1 A](#fig1){ref-type="fig"}, top left) and analyzed over periods of 7.5 min at 3, 4, 5, and 7 d in culture ([Fig. 1 A](#fig1){ref-type="fig"}, bottom left). In parallel to these measurements, motoneuron survival in the presence of brain-derived and ciliary neurotrophic factor (10 ng/ml each) was determined. No difference was observed between Smn-deficient and control motoneurons ([@bib35]). In control *Smn* ^+*/*+^ *; SMN2* motoneurons that were cultured on laminin-111, spontaneous spikelike Ca^2+^ transients were detectable that appeared synchronized in the cell body, dendrites, axons, and axonal growth cones, thus reflecting global spontaneous depolarization as described previously for developing neurons ([@bib12]; [@bib4]). These transients could be blocked by 1 μM tetrodotoxin (TTX), indicating that they are triggered by opening of voltage-gated Na^+^ channels ([Fig. 1 A](#fig1){ref-type="fig"}, top right). The addition of 0.3 and 1.0 μM ω-conotoxin MVIIA (CTX) inhibited these Ca^2+^ transients, suggesting that N-type Ca^2+^ channels are responsible for the Ca^2+^ transients measured in these cultures ([Figs. 1 A](#fig1){ref-type="fig"}, bottom right; and S1 A, available at <http://www.jcb.org/cgi/content/full/200703187/DC1>).

![**Reduced spontaneous Ca^2+^ influx into distal axons of Smn-deficient motoneurons cultured on laminin-111.** (A) Spontaneous Ca^2+^ transients in isolated motoneurons were recorded in cell bodies, proximal axons, and axonal growth cones. These spontaneous Ca^2+^ transients can be inhibited by addition of 1 μM TTX or CTX, respectively. (B and C) The frequency of spontaneous generalized spikelike Ca^2+^ transients was determined on day 3 (*n* = 51/54), 4 (*n* = 91/84), 5 (*n* = 74/84), and 7 (*n* = 20/34) from control (*Smn* ^+*/*+^; *SMN2*) and *Smn* ^−*/*−^ *; SMN2* motoneurons on laminin-111. No difference was observed in cell bodies and proximal axons (B) of *Smn* ^−*/*−^ *; SMN2* motoneurons, but a change was detected in distal axons and growth cones (C), first becoming detectable on day 4 in culture. (D and E--N) Axon length of cultured motoneurons from control and Smn-deficient embryos on laminin-111. Axon length was measured on day 3 (*n* = 129/106), 4 (*n* = 106/87), 5 (*n* = 162/206), 6 (*n* = 59/74), and 7 (*n* = 87/115). (D, G--I, and L--N) After day 4, the difference in axon elongation became significant. Axons of Smn-deficient motoneurons did not extend further after day 4 in comparison with control cells. Results represent the mean ± SEM of pooled data from three independent experiments. *n*, number of motoneurons that were scored in total from control or *Smn* ^−*/*−^ *; SMN2* embryos. \*, P \< 0.05; \*\*, P \< 0.001, tested by one-way ANOVA.](jcb1790139f01){#fig1}

The frequency of spikelike global spontaneous Ca^2+^ transients within cell bodies and proximal axons of control motoneurons (*Smn* ^+*/*+^ *; SMN2*) was highest on day 3, both in *Smn* ^−*/*−^ *; SMN2* and control motoneurons ([Fig. 1 B](#fig1){ref-type="fig"}). It declined after day 3 both in control and *Smn* ^+*/*+^ *; SMN2* motoneurons, confirming previous analyses ([@bib11]), perhaps because the resting potential becomes more negative in embryonic motoneurons that are cultured for longer periods ([@bib49]). There was no difference in local transient frequency in the cell bodies and proximal axons of control and *Smn* ^−*/*−^ *; SMN2* motoneurons ([Fig. 1 B](#fig1){ref-type="fig"}).

We then investigated the frequency of such spikelike spontaneous transients in axons and growth cones ([Fig. 1 C](#fig1){ref-type="fig"}). At day 3 in culture, these transients were less frequent both in control and *Smn* ^−*/*−^ *; SMN2* motoneurons, indicating that not every transient spreads from the cell body and proximal axon to distal axons at this stage. At day 4, spikelike transient frequency was similar in cell bodies and distal axons in control motoneurons. At the same stage, the frequency of spikelike spontaneous Ca^2+^ transients that reached the distal axons and growth cones was significantly reduced in *Smn* ^−*/*−^ *; SMN2* motoneurons (0.39 ± 0.11 min^−1^) in comparison to control *Smn* ^+*/*+^ *; SMN2* cells (0.83 ± 0.18 min^−1^; P \< 0.05). At days 5 and 7, the frequency of these spikelike transients further declined in *Smn* ^−*/*−^ *; SMN2* motoneurons ([Fig. 1 C](#fig1){ref-type="fig"}). TTX and CTX also inhibited these spontaneous Ca^2+^ transients on day 5 in culture (Fig. S1 A). The reduction of Ca^2+^ transients was \>50% at 0.3 μM CTX and increased to ∼80% at 1 μM CTX, indicating that influx through VGCCs is the predominant source of these fast transients of cytosolic Ca^2+^ (Fig. S1 A).

The time course of reduced spontaneous activity in distal axons and growth cones resembles that of axonal growth defects in these cultures. As described previously ([@bib35]), axons in cultured *Smn* ^−*/*−^ *; SMN2* motoneurons are shorter at day 5. Surprisingly, significant differences in axon elongation (P \< 0.05) are not detectable at earlier stages ([Fig. 1, D, E, and J](#fig1){ref-type="fig"}). Normally, between days 3 and 4, a doubling of axon length is observed in cultures of both control and Smn-deficient motoneurons, but the difference between Smn-deficient and control cells was not significant ([Fig. 1, D, F, and K](#fig1){ref-type="fig"}; P \> 0.05). Only at days 5, 6, and 7 did reduced axon length become apparent in the *Smn* ^−*/*−^ *; SMN2* motoneurons ([Fig. 1, D, G--I, and L--N](#fig1){ref-type="fig"}).

These data suggest that defects in axonal Ca^2+^ influx precede alterations in axon growth of cultured *Smn* ^−*/*−^ *; SMN2* motoneurons. However, these defects occur late, starting at E14 plus four additional days in culture (E14 + 4), at a developmental stage when maximal axon elongation has already occurred and motor endplate differentiation progresses in vivo.

Local Ca^2+^ transients in axonal growth cones are enhanced by laminin-211/221 in *Smn* ^−*/*−^ *; SMN2* and control motoneurons
--------------------------------------------------------------------------------------------------------------------------------

To follow the idea that axonal defects become apparent when Smn-deficient motoneurons get in contact with skeletal muscle, we investigated motoneurons on motor endplate--specific forms of laminin (laminin-211/221). Previous papers have shown that neurite growth of motoneurons is reduced on this substrate ([@bib32]; [@bib10]). Furthermore, it has been shown that the β2 chain in laminin-221 interacts with the pore-forming (Ca~v~) subunit of the N-type VGCC (Ca~v~2.2; [@bib28]). Thus, presynaptic differentiation appears mediated through the direct interaction of laminin-221 with Ca~v~2.2 channels. We therefore measured Ca^2+^ transients that only occurred in growth cones ([Fig. 2 A](#fig2){ref-type="fig"}). Such local transients have been identified in many types of developing neurons, including motoneurons, and some of these transients are caused by Ca^2+^ influx through other channels than VGCCs ([@bib39]). Evidence has been presented that the transient receptor potential ion channel 5 (TRPC5) is a channel that can regulate neurite growth and growth cone morphology, at least in hippocampal neurons ([@bib10]). Fast Ca^2+^ transients, which only occur in growth cones but not in proximal axons and cell bodies, were barely detectable on laminin-111, neither in *Smn* ^−*/*−^ *; SMN2* nor in control motoneurons at day 5 in culture ([Fig. 2 B](#fig2){ref-type="fig"}). They were much more frequent on laminin-211/221, both in control (0.22 ± 0.06 min^−1^ on laminin-211/221 vs. 0.04 ± 0.03 min^−1^ on laminin-111) and *Smn* ^−−^ *; SMN2* motoneurons (0.07 ± 0.03 min^−1^ on laminin-211/221 vs. 0.02 ± 0.01 min^−1^ on laminin-111; [Fig. 2 B](#fig2){ref-type="fig"}). In control cultures, ∼50% of these local transients in growth cones could be blocked with CTX (Fig. S1, B and C), indicating that VGCCs are also responsible for some but not all fast local transients in growth cones of isolated embryonic mouse motoneurons. The frequency of these local Ca^2+^ transients was significantly lower in *Smn* ^−*/*−^ *; SMN2* motoneurons on laminin-211/221 at day 5 in culture ([Fig. 2 B](#fig2){ref-type="fig"}, P \< 0.05).

![**Decreased frequency of local spontaneous Ca^2+^ transients in growth cones of *Smn*^−*/*−^*; SMN2* motoneurons on laminin-211/221.** (A) Local Ca^2+^ transients in growth cones (black) were more frequent in *Smn* ^+*/*+^; *SMN2* motoneurons than in *Smn* ^−*/*−^; *SMN2* motoneurons cultured for 5 d. (B) The frequency of local spontaneous Ca^2+^ transients was significantly higher both for control (*n* = 34) and Smn-deficient motoneurons (*n* = 39) on laminin-211/221 in comparison with laminin-111 (*n* = 35/42). Despite the higher frequency on laminin-211/221, local transients on laminin-211/221 were significantly less frequent in Smn-deficient motoneurons in comparison with controls. Results represent the mean ± SEM of pooled data from three independent experiments. *n*, number of motoneurons that were scored in total from control or *Smn* ^−*/*−^ *; SMN2* embryos. \*, P \< 0.05 tested by one-way ANOVA.](jcb1790139f02){#fig2}

Ca~v~2.2 is reduced in axonal growth cones of *Smn* ^−*/*−^ *; SMN2* motoneurons
--------------------------------------------------------------------------------

In embryonic motoneurons, the N-type VGCCs are predominantly expressed ([@bib43]; [@bib38]). These channels are located in axon terminals of motoneurons where they act as receptors for motor endplate--specific forms of laminin ([@bib28]). Because embryonic cultured *Smn* ^−*/*−^ *; SMN2* motoneurons showed reduced spontaneous Ca^2+^ transients in growth cones, we investigated expression and cellular distribution of Ca~v~2.2 in control and Smn-deficient motoneurons ([Fig. 3, A--I and M--O](#fig3){ref-type="fig"}) using polyclonal antibodies against the α2 chain of this channel. The Ca~v~2.2 signal intensity was quantified as arbitrary units based on quantum levels per pixel per area in cell body, proximal axon, and growth cones. A significantly reduced signal intensity (P \< 0.001) was found in growth cones of Smn-deficient motoneurons (8.7 ± 1.1) versus controls (21.9 ± 2.1; [Fig. 3, C--E](#fig3){ref-type="fig"}). Applying a fixation protocol without detergent and shortened exposure to 4% PFA to increase the staining intensity of cell surface--exposed versus intracellular Ca~v~2.2, showed this channel to be highly concentrated in protrusions of control growth cones ([Fig. 3, F and G](#fig3){ref-type="fig"}) but not in *Smn* ^−*/*−^ *; SMN2* growth cones ([Fig. 3, H and I](#fig3){ref-type="fig"}). Furthermore, Ca~v~2.2 channels colocalize with the active zone protein Piccolo, indicating that clusters of Ca~v~2.2 have formed active zone-like structures in the growth cone protrusions in control motoneurons (Fig. S2, A, C, E, and G, available at <http://www.jcb.org/cgi/content/full/200703187/DC1>). The colocalization of Ca~v~2.2 with Piccolo was highly reduced in Smn-deficient growth cones (Fig. S2, B, D, F, and H). In control motoneurons, these active zone-like structures cover ∼20% of the whole growth cone area. In Smn-deficient motoneurons \<5% of the active zone-like structures are detectable (Fig. S2 I). These structures are only found in protrusions but not the core or the proximal parts of growth cones and axons (Fig. S2, J--L). In contrast to growth cones, the signal intensity in cell bodies of *Smn* ^+*/*+^ *; SMN2* and *Smn* ^−*/*−^ *; SMN2* motoneurons was not different ([Fig. 3, A, B, and E](#fig3){ref-type="fig"}).

![**Expression and cellular distribution of Ca~v~2.2 protein and mRNA in primary motoneurons of *Smn*^−*/*−^; *SMN2* and *Smn*^+*/*+^; *SMN2* embryos.** (A--E) Distribution and quantitative analysis of Ca~v~2.2 protein in 7-d-old primary motoneurons of *Smn* ^−*/*−^; *SMN2* and *Smn* ^+*/*+^; *SMN2* embryos on laminin-211/221. The signal intensity for Ca~v~2.2 protein in the cell body of *Smn* ^−*/*−^; *SMN2* motoneurons (A and E; *n* = 30) is not reduced in comparison to control cells (B and E; *n* = 30). In contrast, the signal intensity for Ca~v~2.2 is lower in axonal growth cones of *Smn* ^−*/*−^; *SMN2* motoneurons (D and E; *n* = 30) in comparison to controls (C and E; n = 30). (F--I) Ca~v~2.2 immunoreactivity is highly enriched in growth cone protrusions in control motoneurons (F and G; *n* = 25) but not in Smn-deficient motoneurons (H and I; *n* = 23) that were fixed for short time periods and immunostained in the absence of detergent to enrich staining of extracellular versus intracellular Ca~v~2.2. (J and K) Differences in *Ca~v~*2.2 mRNA distribution are not detected in cell bodies (arrows) and growth cones (arrowheads and insets) of motoneurons from *Smn* ^−*/*−^; *SMN2* embryos (*n* = 35) in comparison to controls (*n* = 32). (L) The specificity of the antisense probe was tested with a sense *Ca~v~*2.2 cDNA probe. (M and N) For high-resolution microscopy, STED microscopy was applied to reduce the focal spot area by one order of magnitude, thus allowing the distinction of small vesicle-like structures (arrowheads) from larger areas that probably (as discussed in the text) reflect clusters at the cell surface (arrows). (O) The ratio between vesicles and clusters is increased in Smn-deficient motoneurons, caused by a significant reduction of the cluster-like structures in *Smn* ^−*/*−^; *SMN2* growth cones (N and O) in contrast to growth cones of control motoneurons (M and O). Results represent the mean ± SEM of pooled data from three independent experiments. *n*, number of motoneurons that were scored in total from control or *Smn* ^−*/*−^ *; SMN2* embryos. \*, P \< 0.05; \*\*, P \< 0.001, tested by one-way ANOVA and *t* test, respectively.](jcb1790139f03){#fig3}

To analyze whether the reduced Ca~v~2.2 expression in distal axons is caused by disturbed subcellular distribution of the corresponding mRNA, in situ hybridization was performed. This experiment did not reveal any difference in cellular distribution or rough differences in expression levels between control and Smn-deficient motoneurons ([Fig. 3, J and K](#fig3){ref-type="fig"}). The specificity of the in situ hybridization was controlled with a Ca~v~2.2 sense probe ([Fig. 3 L](#fig3){ref-type="fig"}).

We also applied stimulated emission depletion (STED) fluorescence microscopy ([@bib7]; [@bib17]; [@bib46]) to investigate whether the reduced accumulation of Ca~v~2.2 reflects a defect in cluster formation of this channel. This method enhances the resolution of confocal microscopy in the xy axis, so that structures \<200 nm that normally cannot be resolved by classical light microscopy become detectable. Intracellular vesicles containing Ca~v~2.2 channels are much smaller than the Ca~v~2.2 clusters that form on the cell surface. When we compared the size of the Ca~v~2.2 immunoreactive areas in control and *Smn* ^−*/*−^ *; SMN2* growth cones, it became apparent that in Smn-deficient growth cones the relative density of large clusters covering an area of at least 0.01 μm^2^ versus small vesicles is reduced compared with control growth cones ([Fig. 3, M--O](#fig3){ref-type="fig"}). Collectively, these data suggest that a defect in Ca~v~2.2 transfer into the cell membrane and active zone-like structures in Smn-deficient growth cones is responsible for reduced frequency of Ca^2+^ transients.

Inhibition of axon elongation by laminin-211/221 does not occur in *Smn* ^−*/*−^ *; SMN2* motoneurons
-----------------------------------------------------------------------------------------------------

In parallel to Ca^2+^ transients, we also analyzed axon elongation on laminin-211/221. Mean axon length of control motoneurons was 264.1 ± 11.2 μm on laminin-211/221 in comparison to 335.2 ± 19.0 μm on laminin-111 after 7 d in culture ([Fig. 4, A, B, and D](#fig4){ref-type="fig"}). Surprisingly, Smn-deficient motoneurons did not show such a reduction of axon growth on laminin-211/221. In contrast, they exhibited a slight but significant (P \< 0.05) increase in axon extension (309.2 ± 12.5 μm) in comparison with control motoneurons (259.6 ± 10.3 μm) on laminin-211/221 ([Fig. 4, A, C, and E](#fig4){ref-type="fig"}).

![**Axon growth and growth cone morphology of *Smn*^−*/*−^; *SMN2* motoneurons on laminin-211/221.** (A--E) Axon length of control and Smn-deficient motoneurons on laminin-111 and laminin-211/221 after 7 d in culture. (A--C) Axons of *Smn* ^−*/*−^; *SMN2* motoneurons (*n* = 210) are shorter than those of control motoneurons (*n* = 93) on laminin-111. (A, D, and E) In contrast, axons of *Smn* ^−*/*−^; *SMN2* motoneurons (*n* = 141) extend significantly longer on laminin-211/221. (F--J) Growth cones of Smn-deficient motoneurons are significantly smaller both on laminin-111 (F--H; *n* = 32) and laminin-211/221 (F, I, and J; *n* = 30). Results represent the mean ± SEM of pooled data from three independent experiments. *n*, number of motoneurons that were scored in total from control or *Smn* ^−*/*−^; *SMN2* embryos. \*, P \< 0.05; \*\*, P \< 0.001, tested by one-way ANOVA.](jcb1790139f04){#fig4}

We then measured the size of axonal growth cones because previous studies have shown that the deficit in axonal β-actin mRNA and protein correlates with reduced axon elongation and growth cone size in *Smn* ^−*/*−^ *; SMN2* motoneurons that were cultured on laminin-111 ([@bib35]). The growth cone area of Smn-deficient motoneurons on laminin-211/221 did not differ from the area on laminin-111 ([Fig. 4, F, H, and J](#fig4){ref-type="fig"}). On both substrates, growth cones of *Smn* ^−*/*−^ *; SMN2* motoneurons were smaller than those of *Smn* ^+*/*+^ *; SMN2* motoneurons ([Fig. 4, F--J](#fig4){ref-type="fig"}).

Blockade of N-type Ca^2+^ channels does not reduce axon growth in Smn-deficient motoneurons
-------------------------------------------------------------------------------------------

Inhibition of Ca~v~2.2 with CTX blocks global Ca^2+^ transients in control motoneurons by \>80% (Fig. S1 A). In addition, local transients that only occur in axonal growth cones are reduced by \>50%, both at 1 and 0.3 μM CTX, which is considered to be highly specific for N-type VGCCs (Fig. S1, A--C). Interestingly, the reduction of local transients in growth cones is smaller, thus confirming earlier observations with *Xenopus laevis* motoneurons that other Ca^2+^ channels contribute to rapid local Ca^2+^ transients in growth cones ([@bib40]). To determine the role of classical VGCCs for axon growth, we tested whether specific blockade of Ca~v~2.2 with CTX affects axon growth of motoneurons in vitro. CTX was applied at 1 μM and a lower concentration (0.3 μM) that is considered highly specific for N-type VGCCs ([Figs. 5](#fig5){ref-type="fig"} and S1). After 7 d in culture, motoneurons grown on laminin-111 or laminin-211/221 were fixed and stained against tau and microtubule-associated protein 2 to distinguish dendrites and axons ([@bib35]). 1 μM CTX specifically reduces axon growth of control motoneurons on laminin-111 (335.2 ± 19.0 vs. 240.7 ± 8.5 μm), whereas 0.3 μM CTX was less efficient (335.2 ± 19.0 vs. 288.2 ± 11.8 μm; [Fig. 5 A](#fig5){ref-type="fig"}). Axon growth of Smn-deficient neurons on laminin-111 (233.4 ± 13.8 μm), which was already disturbed, was not further reduced both by 1 and 0.3 μM CTX ([Fig. 5 A](#fig5){ref-type="fig"}).

![**Axon growth after blockade of Ca~v~2.2. with CTX in *Smn*^−*/*−^; *SMN2* and control motoneurons.** (A and B) Axon length of 7-d-old isolated motoneurons from control and Smn-deficient embryos that were grown on laminin-111 (A) and laminin-211/221 (B) treated with 1 and 0.3 μM CTX, respectively. (A) On laminin-111, control neurons responded to 1 (*n* = 162) and 0.3 μM CTX (*n* = 186) with reduced axon growth, whereas Smn- deficient cells were unaffected in the presence of both concentrations (*n* = 151 for 1 μM and *n* = 82 for 0.3 μM CTX). (B) On laminin-211/221, CTX-treatment, both with 1 and 0.3 μM, increases axon extension in control motoneurons (*n* = 99 for 1 μM and *n* = 59 for 0.3 μM CTX) but not in Smn-deficient neurons (*n* = 102 for 1 μM and *n* = 82 for 0.3 μM CTX). Results represent the mean ± SEM of pooled data from three independent experiments. *n*, number of motoneurons that were scored in total from control or *Smn* ^−*/*−^; *SMN2* embryos. \*, P \< 0.05; \*\*, P \< 0.001, tested by one-way ANOVA.](jcb1790139f05){#fig5}

We then investigated the effect of 0.3 and 1 μM CTX on motoneurons grown on laminin-211/221. Inhibition of Ca~v~2.2 with CTX led to an increase in axon growth in control motoneurons ([Fig. 5 B](#fig5){ref-type="fig"}) at both concentrations. Axon elongation reached comparable levels to those seen in motoneurons on laminin-111 ([Fig. 5 A](#fig5){ref-type="fig"}). Smn-deficient motoneurons did not show increased axon elongation after 0.3 and 1 μM CTX treatments ([Fig. 5 B](#fig5){ref-type="fig"}), indicating that the response of axonal growth to blockade of N-type Ca^2+^ channels is lacking in Smn-deficient motoneurons. Low concentrations (0.3 μM) of CTX showed similar effects as 1 μM CTX on laminin-211/221, thus providing an argument for the specificity of the effect for Ca~v~2.2 channels.

In other types of neurons, TRPC3 and 6 have been shown to mediate Ca^2+^ fluxes that modulate axon guidance and neuronal survival in response to brain-derived neurotrophic factor ([@bib20]; [@bib15]). In addition, TRPC5 activation promotes axon guidance and neurite growth in hippocampal neurons ([@bib10]). Therefore, the possibility exists that TRPCs are also involved in the pathological alterations observed in Smn-deficient motoneurons. Among these candidates, TRPC5 is highly expressed in embryonic motoneurons. TRPC6 is also found but at relatively lower levels, whereas TRPC3 is barely detectable (unpublished data). When we analyzed the distribution of TRPC5 and 6 immunoreactivity in growth cones of control and Smn-deficient motoneurons, no difference was observed, both with respect to subcellular distribution (Fig. S3, A--D, available at <http://www.jcb.org/cgi/content/full/200703187/DC1>) and signal intensity (Fig. S3, E and F). This led us to conclude that alteration in Ca~v~2.2 distribution is responsible for the differences in Ca^2+^ transients observed in growth cones of Smn-deficient motoneurons.

8-(4-chlorophenylthio)--3′,5′ cAMP (8-CPT-cAMP) enhances SMN protein in *Smn* ^−/−^ *; SMN2* motoneurons and restores morphological and functional alterations in axons
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------

We further tested whether cAMP, which has previously been described to enhance the frequency of spontaneous Ca^2+^ transients in developing *Xenopus* motoneurons ([@bib9]), could enhance the frequency of Ca^2+^ transients in growth cones of control and Smn-deficient mouse motoneurons. Surprisingly, there was only little effect (P \> 0.05) in cultured control motoneurons ([Fig. 6 A](#fig6){ref-type="fig"}). In contrast, *Smn* ^−*/*−^ *; SMN2* axonal growth cones react with a more than twofold increase in the frequency of Ca^2+^ transients on day 5 in axon terminals after treatment with 100 μM 8-CPT-cAMP. To test whether 8-CPT-cAMP has a direct effect on Ca^2+^ transients, we added CTX together with 8-CPT-cAMP (Fig. S1, C and D). Enhanced cAMP does not rescue the reduction of Ca^2+^ transients that is caused by CTX (Fig. S1 C), indicating that there are no CTX-insensitive channels present that open in response to 8-CPT-cAMP. When we treated *Smn* ^−*/*−^ *; SMN2* motoneurons with CTX, there was little further reduction of local Ca^2+^ transients, but treatment with 8-CPT-cAMP increases Ca^2+^ transient frequency (Fig. S1 D). This improvement only occurs in *Smn* ^−*/*−^ *; SMN2* but not in control motoneurons, leading to similar levels of Ca^2+^ transients than those observed with CTX and 8-CPT-cAMP in control motoneurons (Fig. S1 C). The difference between control and Smn-deficient motoneurons suggests that the improvement is not caused by the opening of VGCCs that were blocked by CTX treatment, because this increase in Ca^2+^ transients should then occur in both groups and not only in *Smn* ^−*/*−^ *; SMN2* motoneurons.

![**8-CPT-cAMP treatment restores local Ca^2+^ transients and N-type Ca^2+^ channel (Ca~v~2.2) immunoreactivity in axonal growth cones of *Smn*^−*/*−^; *SMN2* motoneurons.** (A) Local Ca^2+^ transients in growth cones of Smn- deficient motoneurons (*n* = 30) that were cultured for 5 d on laminin-211/221 are restored by 8-CPT-cAMP in comparison with controls (*n* = 30). (B) Quantitative analysis of immunoreactivity for Ca~v~2.2 and β-actin in 5-d-old control (white bar; *n* = 30), *Smn* ^−*/*−^; *SMN2* (gray bar; *n* = 30), and 8-CPT-cAMP--treated *Smn* ^−*/*−^ *; SMN2* motoneurons (checkered bar; *n* = 30) cultured on laminin-211/221. (C--E) In control motoneurons, Ca~v~2.2 (C and D) and β-actin (E) are enriched in axonal growth cones. (F--H) Smn-deficient motoneurons exhibit reduced Ca~v~2.2 and β-actin accumulation in comparison to controls. (B \[checkered bar\] and I--K) The reduction of signal intensity for Ca~v~2.2 and β-actin is restored by 100 μM 8-CPT-cAMP. Results represent the mean ± SEM of pooled data from three independent experiments. *n*, number of motoneurons that were scored in total from control or *Smn* ^−*/*−^; *SMN2* embryos. \*, P \< 0.05; \*\*, P \< 0.001, tested by one-way ANOVA.](jcb1790139f06){#fig6}

We then analyzed whether this increase of Ca^2+^ transients in 8-CPT-cAMP--treated Smn-deficient motoneurons correlates with increased Ca~v~2.2 expression in Smn-deficient growth cones. Both the signal intensity of the Ca~v~2.2 staining ([Fig. 6, B--D, F, G, I, and J](#fig6){ref-type="fig"}) and β-actin in growth cones ([Fig. 6, B, C, E, F, H, I, and K](#fig6){ref-type="fig"}) was increased to almost normalized levels by this treatment.

The *Smn* promoter region contains a CreII-binding element ([@bib22]) that mediates cAMP effects on increased *SMN2* transcription in mouse hepatocytes. We therefore tested whether cAMP up-regulates Smn expression and thus restores the morphological and functional alterations in Smn-deficient motoneurons. For this purpose we analyzed Smn protein levels and distribution in cultured embryonic motoneurons. Because the number of motoneurons that can be isolated from one Smn-deficient embryo is not sufficient for quantitative RT-PCR or Western blot analysis, we prepared protein and RNA extracts from cultures of E11.5 forebrain neuronal precursor cells from control and Smn-deficient mice. 100 μM 8-CPT-cAMP increased *SMN2* mRNA (Fig. S4, A and B, available at <http://www.jcb.org/cgi/content/full/jcb.200703187/DC1>) and protein levels by ∼40--100% (Fig. S4 C) in these cells.

Primary motoneurons from *Smn* ^−*/*−^ *; SMN2* and *Smn* ^+*/*+^ *; SMN2* embryos were treated with 100 μM 8-CPT-cAMP. Both in cell bodies, axons, and axonal growth cones, Smn-specific fluorescence signal intensity was enhanced in Smn-deficient neurons but not fully restored to control levels ([Fig. 7, A--J](#fig7){ref-type="fig"}). The reduction of growth cone size is the most prominent pathological feature in cultured *Smn* ^−*/*−^ *; SMN2* motoneurons ([@bib35]). 8-CPT-cAMP treatment normalized growth cone size in *Smn* ^−*/*−^ *; SMN2* motoneurons to control levels and CTX did not abolish the rescue effect, indicating that it does not involve enhanced Ca^2+^ transients ([Fig. 8, A--E](#fig8){ref-type="fig"}). We then investigated whether this effect is caused by a normalization of local β-actin levels in distal axons. The ratio of distal to proximal β-actin protein levels is reduced in *Smn* ^−*/*−^ *; SMN2* motoneurons ([@bib35]), and this ratio was normalized by 8-CPT-cAMP ([Fig. 8 F](#fig8){ref-type="fig"}). The altered β-actin ratio is based on increased actin mRNA in the growth cone of 8-CPT-cAMP--stimulated Smn-deficient motoneurons ([Fig. 8, G--N](#fig8){ref-type="fig"}). Thus, elevated cAMP increases distal actin mRNA and protein levels in axons, leading to augmented Ca~v~2.2 levels in growth cones and normalization of Ca^2+^ transient frequency. Subsequently, we tested whether this effect also rescues responsiveness to laminin-211/221 in the *Smn* ^−*/*−^ *; SMN2* motoneurons. As shown in [Fig. 8 (O--R)](#fig8){ref-type="fig"}, axon length is shortened in *Smn* ^−*/*−^ *; SMN2* neurons on laminin-211/221 when the cells are treated with 8-CPT-cAMP, indicating that the responsiveness to motor endplate-specific forms of laminin is restored by elevated cAMP levels.

![**Smn protein distribution in control and *Smn*^−*/*−^; *SMN2* motoneurons after treatment with 8-CPT-cAMP.** (A--I) Distribution of Smn protein in cell body (A--C), axon (D--F), and growth cones (G--I) of *Smn* ^+*/*+^; *SMN2* (A, D, and G), *Smn* ^−*/*−^; *SMN2* (B, E, and H), and 8-CPT-cAMP--treated *Smn* ^−*/*−^; *SMN2* (C, F, and I) primary motoneurons cultured for 7 d on laminin-211/221. 100 μM 8-CPT-cAMP increases Smn immunoreactivity in cell bodies, axons, and growth cones of *Smn* ^−*/*−^; *SMN2* motoneurons (*n* = 20 for controls, *n* = 20 for *Smn* ^−*/*−^; *SMN2*, and *n* = 20 for *Smn* ^−*/*−^; *SMN2* treated with 100 μM 8-CPT-cAMP). (J) Quantitative analysis of *Smn* immunoreactivity revealed a significant *Smn* increase in 8-CPT-cAMP--treated motoneurons (checkered bars) in comparison to untreated *Smn* ^−*/*−^; *SMN2* motoneurons. Results represent the mean ± SEM of pooled data from three independent experiments. *n*, number of motoneurons that were scored in total from control, *Smn* ^−*/*−^; *SMN2*, or *Smn* ^−*/*−^; *SMN2* embryos treated with 100 μM 8-CPT-cAMP. \*, P \< 0.05; \*\*, P \< 0.001, tested by one-way ANOVA.](jcb1790139f07){#fig7}

![**8-CPT-cAMP restores axon elongation, growth cone size, and responses to laminin-211/221 in *Smn*^−*/*−^; *SMN2* motoneurons.** (A--E) The smaller growth cone size of 7-d-old *Smn* ^−*/*−^; *SMN2* motoneurons (A and C) is rescued by 100 μM 8-CPT-cAMP (A \[gray checkered bar\] and D) and reaches the size of control motoneurons (A, B, and D), also in the presence of CTX (A and E; *n* = 30 for each genotype with and without 100 μM 8-CPT-cAMP). (F) Ratio of β-actin content in the most distal part of the axon and the most proximal part of the axon. *Smn* ^−*/*−^; *SMN2* motor axons (*n* = 82) show reduced distal β-actin signal intensity in comparison to control cells (*n* = 78). 8-CPT-cAMP treatment of *Smn* ^−*/*−^; *SMN2* restores distal β-actin levels (checkered gray bar; *n* = 90). (G--N) Analysis of actin mRNA levels in axonal growth cones by in situ hybridization in motoneurons from *Smn* ^−*/*−^; *SMN2* (G, I, and L; *n* = 30), 8-CPT-cAMP--treated *Smn* ^−*/*−^; *SMN2* (G, J, and M; *n* = 32), and control embryos (G, H, and K; *n* = 30). (G, J, and M) 8-CPT-cAMP restores the actin mRNA deficit in axon terminals of *Smn* ^−*/*−^; *SMN2* motoneurons. (N) A sense actin probe was used as a negative control for the specificity of the actin probe. (O--R) 8-CPT-cAMP also restores the response of *Smn* ^−*/*−^; *SMN2* motor axons to laminin-211/221. Axon elongation after 7 d on laminin-211/221 in control (P; *n* = 141), *Smn* ^−*/*−^; *SMN2* (Q; *n* = 141) and 8-CPT-cAMP--treated *Smn* ^−*/*−^; *SMN2* (R; *n* = 60) motoneurons. (O) Quantitative analysis of data. Results represent the mean ± SEM of pooled data from three independent experiments. *n*, number of motoneurons that were scored in total from control, *Smn* ^−*/*−^; *SMN2*, or *Smn* ^−*/*−^; *SMN2* embryos were treated with 100 μM 8-CPT-cAMP. \*, P \< 0.05; \*\*, P \< 0.001, tested by one-way ANOVA.](jcb1790139f08){#fig8}

Discussion
==========

We have investigated the correlation between defective axon elongation and spontaneous excitability in motoneurons from a mouse model of SMA. We observed that the reduction of spontaneous Ca^2+^ transients in distal axons and growth cones is caused by defective Ca~v~2.2 accumulation and clustering in the axonal growth cones, thus influencing axon growth in the Smn-deficient motoneurons. These defects can be at least partially compensated by 8-CPT-cAMP treatment. Motoneuron disease in SMA, both in humans and mouse models, becomes apparent after motoneurons have made contact with skeletal muscle. In a mouse model of SMA type I, motoneuron loss is not enhanced during a critical period of development when motoneurons depend on trophic support from target tissues ([@bib26]). Motoneuron numbers are normal at birth, but decrease at postnatal days 3--5. During this period, differentiation of motor endplates takes place, and we therefore investigated neurons that were cultured on motor endplate--specific forms of laminin (laminin-211/221). Previous papers have shown that neurite growth of motoneurons is impaired on this substrate ([@bib32]). Furthermore, it has been shown that the β2 chain in laminin-221 interacts with the pore-forming (Ca~v~) subunit of the N- and P/Q-type--specific VGCC (Ca~v~2.2 and Ca~v~2.1; [@bib28]), indicating that presynaptic differentiation is mediated through the direct interaction of laminin-221 with Ca~v~2.2 channels. Smn-deficient motoneurons exhibit a reduced accumulation of Ca~v~2.2 channels in growth cones. This finding correlates with reduced Ca^2+^ influx and reduced spontaneous electrical activity in this part of the neuron.

Gene knockout mice for the laminin β2 chain (*Lamb2* ^−*/*−^) or Ca~v~2.1 (*Ca~v~2.1* ^−*/*−^) exhibit strong synaptic maturation defects. Lamb2-deficient mice develop neuromuscular junction (NMJ) degeneration, which is characterized by disturbed active zones just after birth ([@bib14]; [@bib28]). *Ca~v~*2.2 knockout mice do not show any signs of motoneuron disease, as the defect can most probably be compensated by Ca~v~2.1 expression. Ca~v~2.1-deficient mice develop normally until the third postnatal week ([@bib16]). But from this time point on, as in *Lamb2* ^−*/*−^ mice, the NMJs degenerate and exhibit a decrease of active zone proteins ([@bib28]; [@bib8]). The delayed disease onset in Ca~v~2.1-deficient mice can be explained by a compensatory effect of residual Ca~v~2.2, which is substituted postnatally by Ca~v~2.1. Altogether, these data indicate that the β2 chain interaction of laminin-221 with Ca~v~2.1 and Ca~v~2.2 supports postnatal development and maintenance of NMJs ([@bib28]). Our data suggest that the reduced Ca~v~2.2 accumulation in the axonal growth cone protrusions of Smn-deficient motoneurons is responsible for reduced axon elongation in cell culture and reduced responsiveness to synapse-specific laminin isoforms.

Mislocalization of N-type Ca^2+^ channels in Smn-deficient motoneurons on laminin-211/221 leads to local excitability defects at the growth cone
------------------------------------------------------------------------------------------------------------------------------------------------

In patients with SMA, extended neuromuscular latency to electrical stimulation is observed ([@bib18]), pointing to defects in synaptic transmission at motor endplates. SMA is a dying-back disease in which the degeneration of motoneurons starts at the presynaptic part and proceeds backward to the cell body ([@bib5]). Fly mutants lacking Smn show reduced excitatory postsynaptic currents and disorganized synaptic boutons, pointing to defects in synaptic function at NMJs ([@bib3]). Such fly models provide further evidence for disturbed actin metabolism ([@bib33]).

Target-derived signals play a critical role for presynaptic differentiation and maintenance during the period when synapses are eliminated and polysynaptic innervation of skeletal muscle fibers is removed ([@bib27]). β2-containing laminin isoforms act as signals for presynaptic differentiation ([@bib37]). The disturbed presynaptic synthesis of β-actin in Smn-deficient motoneurons interferes with VGCC translocalization to membrane clusters, which, in turn, could impair transmitter release from the axon terminals ([@bib48]). Interestingly, other types of Ca^2+^ channels such as TRPC5 and 6 are not affected. These channels do not cluster on growth cone protrusions and are distributed more widespread over the growth cone. Moreover, double staining with Piccolo, a component of the presynaptic apparatus, revealed a severe defect of Ca~v~2.2 accumulation into active zone-like structures of Smn-deficient motoneurons.

Control motoneurons show reduced axon elongation on laminin-211/221 that correlates with increased Ca^2+^ spike frequency in axonal growth cones. The contribution of Ca~v~2.2 accumulation and subsequent enhanced frequency of Ca^2+^ transients to axon elongation on laminin-211/221 becomes evident by CTX treatment. Ca~v~2.2 inhibition restores axon elongation on laminin-221/211. The lack of response of Smn-deficient motoneurons to laminin-211/221 could be explained by a massive reduction of Ca^2+^ transients in the growth cone.

Collectively, we conclude that Smn-deficient motoneurons are not able to differentiate in response to synapse-specific laminins because of their incapability of accumulating Ca~v~2.2 in axon terminals. Thus, defective Ca^2+^ channel accumulation could lead to dysfunction of the active zone ([@bib28]), and this in turn could lead to disturbed neurotransmitter release and thus to degeneration of NMJs.

cAMP compensates for the morphological and functional defects in Smn-deficient motoneurons
------------------------------------------------------------------------------------------

We also found that 8-CPT-cAMP restored the defect in excitability in axon terminals of *Smn* ^−*/*−^ *; SMN2* motoneurons. 8-CPT-cAMP treatment enhances spontaneous Ca^2+^ influx into spinal motoneurons of *Xenopus* oocytes through VGCCs ([@bib9]). In addition, the ratio of cAMP to cGMP has been reported to regulate polarity in netrin-1--induced axon guidance in *Xenopus* spinal motoneurons ([@bib29]). The enhanced frequency of spontaneous Ca^2+^ transients in axonal growth cones of *Smn* ^−*/*−^ *; SMN2* motoneurons correlates with increased Ca~v~2.2 accumulation in growth cones. It appears as if this defect is reversed by increased β-actin protein level in distal axons of *Smn* ^−*/*−^ *; SMN2* motoneurons. Thus, our results with 8-CPT-cAMP could guide the way to new therapeutic strategies for SMA.

Materials and methods
=====================

Motoneuron culture
------------------

The ventrolateral part of the lumbar spinal cord of E14 embryos was dissected and transferred to HBSS. After 15 min of treatment with 0.05% trypsin, cells were triturated and cultured after enrichment by panning with antibodies against the mouse p75 neurotrophin receptor (Abcam). Cells were plated at a density of 2,000 cells/cm^2^ in 4-well dishes (Greiner Bio-One) and cultured as described previously ([@bib45]). The culture dishes were precoated with polyornithine and laminin-111 or laminin-211/221 (Invitrogen), respectively. 100 μM 8-CPT-cAMP (dissolved in HBSS; Calbiochem), 1 μM TTX (Sigma-Aldrich), and 1 or 0.3 μM CTX (Sigma-Aldrich), respectively, was added by changing the medium every second day.

Forebrain neuronal precursor cell culture
-----------------------------------------

Precursor cells from the forebrain of 11.5-d-old mouse embryos were prepared, and neurospheres were cultured in neurobasal medium with 500 μM glutamax (Invitrogen), 50 U/ml penicillin G sodium and 50 U/ml streptomycin sulfate (Invitrogen), B27 (1:50; Invitrogen), and 20 ng/ml EGF and bFGF (Cell Concepts).

For Western blot analysis, the neurospheres were plated at high density on 60-mm dishes that had been coated with poly ornithine and laminin-111. These cells were then grown for 72 h.

Antibodies used for immunocytochemistry
---------------------------------------

Immunocytochemistry was performed as described previously ([@bib35]). For analysis of membrane-exposed N-type Ca^2+^ channels, we fixed the cells only for 2 min with 4% PFA in 1× TBS without acetone. In addition, Tween 20 (Sigma-Aldrich) was omitted from all buffers for this set of experiments ([Fig. 3, F--I](#fig3){ref-type="fig"}). The following primary antibodies were used: rabbit polyclonal antibodies against tau at 1 μg/ml (1:1,000; Sigma-Aldrich), an N-type Ca^2+^ channel (1:200; Sigma-Aldrich), TRPC5 (1:200, Sigma- Aldrich), and TRPC6 (1:200, Chemicon), mouse monoclonal antibodies against 1 μg/ml β-actin (Abcam), 1 μg/ml microtubule-associated protein 2 (Sigma-Aldrich), and 2 μg/ml Smn (BD Biosciences). Cells were then washed three times with 1× TBS-T (20 mM Tris-HCl, pH 7.6, 137 mM NaCl, and 0.1% Tween 20) and incubated for 1 h at room temperature with Cy2 (1:200)- and Cy3 (1:300)-conjugated secondary antibodies (Dianova). The Atto 647N--conjugated secondary antibody (Atto Technology) was used for STED microscopy. Confocal images were obtained either with a microscope (TCS 4D; Leica) with a 20× 0.5 objective (PL FLUOTAR) or a microscope (SP2; Leica) with a 100× 1.4 oil-immersion objective (HCX PL APO CS), with identical settings for pinhole and voltage for control and Smn-deficient motoneurons. For high-resolution microscopy, a STED setup mounted to a microscope (SP5; Leica) with a 100× 1.4 oil immersion objective was applied.

Western blot analysis
---------------------

Forebrain neuronal precursor cells grown on laminin-111 for 72 h were collected from the dishes, and protein extraction for Western Blotting was performed as described previously ([@bib34]). Primary antibodies, 1 μg/ml anti--mouse β-actin antibody (Abcam), 1 μg/ml anti--mouse β-III tubulin antibody (RDI), and 2 μg/ml Smn IgG1 (BD Biosciences) were used.

Calcium imaging
---------------

For Ca^2+^ imaging analysis, cultured motoneurons were grown on glass coverslips. After gently washing in phenol red--free HBSS and permeabilization with 0.25% pluronic F-127 (Sigma-Aldrich) over 5 min, cells were loaded with 2 μM FURA-2 AM (Invitrogen) at 37°C for 45 min in Ca^2+^ and Mg^2+^ containing HBSS. After washing, coverslips were mounted on a heated microscope stage (37°C) and constantly superfused with Ca^2+^/Mg^2+^-HBSS under linear flow conditions.

Measurements were performed by dual-excitation and dual-emission ratio imaging using a microscope fluorescence measurement workstation (Polychrome II; TILL Photonics). Motoneurons were alternately exposed to monochromatic light of 340 and 380 nm, and emission was measured at 512 nm. Real-time microscope imaging was performed using a microscope (Axiovert S100TV; Carl Zeiss MicroImaging, Inc.) equipped for epifluorescence with a dichroid mirror, a 100× 1.3 oil-immersion objective (Fluor; Carl Zeiss MicroImaging, Inc.), and a charge-coupled device camera (IMAGO; TILL Photonics).

Images were acquired at a frequency of 1 Hz and exposure time was 10 ms. The measurements in proximal axons were taken at a distance of 10--30 μm from the cell body. Spontaneous Ca^2+^ transients (340:380) were recorded separately in cell bodies, dendrites, axons, and growth cones over a time period of 7.5 min.

Permeabilizing the motoneurons with 20 μM digitonin allowed background signal detection after cytosolic dye release for background correction. Cells were constantly superfused with Ca^2+^/Mg^2+^-HBSS over the registration time.

In situ hybridization
---------------------

Hybridization solution containing 3′ biotinylated sense or antisense actin or N-type Ca^2+^ channel oligonucleotides (200 ng/ml; GeneDetect) was applied to the coverslips. Hybridization was performed as described previously ([@bib35]). Images were acquired using a microscope (Axiophot; Carl Zeiss MicroImaging, Inc.) equipped with a charge-coupled device camera using Axioplan 2 software (Carl Zeiss MicroImaging, Inc.).

RT-PCR from neuronal stem cells
-------------------------------

Total RNA from neuronal precursor cells was extracted by Trizol (Invitrogen) according to the manufacturer\'s protocol, and 1 μg of total RNA was used for cDNA amplification. Amplification of the *SMN2* cDNA was performed with Ex 5f (5′-CCACTTACTATCATGCT-3′) and Ex 8r (5′-CTACAACACCCTTCTCACAG-3′) primers under the following PCR conditions: 3 min at 94°C (1 cycle), 30 s at 94°C, 30 s at 56°C, 45 s at 72°C (30 cycles), and 5 min at 72°C (1 cycle).

Data analysis
-------------

Axons of motoneurons were identified by their length as processes that are at least two times longer than dendrites. Only the longest axonal branches were measured. Cultures obtained from mutant and control embryos from different litters were analyzed under a microscope (TCS4D; Leica), and axon length was measured from pictures using image software (Scion Corporation).

For the quantification of β-actin and N-type Ca^2+^ channel distribution within the different cellular compartments, the staining intensity in the cell body, the proximal and the distal third of the axon, and the growth cone were analyzed with AIDA software (Raytest). Background intensity was measured for every single picture. The intensity for β-actin and N-type Ca^2+^ channels was measured as arbitrary units per area, based on quantum levels per pixel, according to the manufacturer\'s instructions.

For STED microscopy, LAS AF acquisition software (modified by Leica) was used. The deconvolution processing was performed with Inspector (Max-Planck Institute).

The final processing of all images was performed with Photoshop 7.0 (Adobe) and Illustrator 10 (Adobe). Linear contrast enhancement was applied to [Figs. 1 (E--N)](#fig1){ref-type="fig"}, [4 (B--E)](#fig4){ref-type="fig"}, and [8 (P--R)](#fig8){ref-type="fig"}, and all individual panels contained in these figures were treated similarly.

Values from at least three independent experiments were pooled and the results were expressed as the mean ± SEM. Statistical significance of differences were assessed by one-way analysis of variance (ANOVA) and Bonferroni after testing using Prism software (GraphPad).

Online supplemental material
----------------------------

Fig. S1 shows that Ca^2+^ transient frequency is reduced by TTX and CTX in cultured motoneurons from 14-d-old mouse embryos. Fig. S2 shows colocalization of Ca~v~2.2 and the presynaptic protein Piccolo in protrusions of axonal growth cones in control and *Smn* ^−*/*−^ *; SMN2* motoneurons. Fig. S3 shows distribution and semiquantitative analysis of TRPC5 and 6 immunoreactivity in the growth cones of control and Smn-deficient motoneurons. Fig. S4 shows that 8-CPT-cAMP stimulates *SMN2* and *Smn* transcription and increases Smn protein levels in Smn-deficient forebrain neuronal precursor cells. Online supplemental material is available at <http://www.jcb.org/cgi/content/full/200703187/DC1>.
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